Vera Therapeutics Inc. (VERA)
NASDAQ: VERA
· Real-Time Price · USD
18.86
-0.18 (-0.95%)
At close: May 28, 2025, 3:59 PM
18.86
-0.03%
After-hours: May 28, 2025, 04:47 PM EDT
-0.95% (1D)
| Bid | 18.29 |
| Market Cap | 1.2B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -175.46M |
| EPS (ttm) | -3 |
| PE Ratio (ttm) | -6.29 |
| Forward PE | -5.76 |
| Analyst | Buy |
| Ask | 21.5 |
| Volume | 760,841 |
| Avg. Volume (20D) | 1,018,275 |
| Open | 19.20 |
| Previous Close | 19.04 |
| Day's Range | 18.86 - 19.36 |
| 52-Week Range | 18.53 - 51.61 |
| Beta | 1.28 |
About VERA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VERA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VERA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-6.08%
Vera Therapeutics shares are trading lower. The co...
Unlock content with
Pro Subscription
7 months ago
-9.23%
Vera Therapeutics shares are trading lower after the company announced plans to commence a public offering to issue and sell $300 million of its Class A common stock.
2 weeks ago · seekingalpha.com
Vera Therapeutics: Huge Catalyst Upcoming For Kidney Disease DrugI am maintaining my 'Hold' rating on Vera Therapeutics from January 2024 despite initial strong stock gains and positive Phase 2b data for atacicept, before a collapse in stock value. In my last note,...